Kebriaei, Razieh
Abdul-Mutakabbir, Jacinda C.
Stamper, Kyle C.
Lev, Katherine L.
Rybak, Michael J. http://orcid.org/0000-0002-1094-043X
Article History
Received: 11 August 2023
Accepted: 14 September 2023
First Online: 5 October 2023
Declarations
:
: Michael J Rybak has received research grant support, consulted, or provided lectures for Allergan, Bayer, Merck, Spero, Melinta, and Paratek. Michael J Rybak is also supported in part by NIAID R01 AI12400. All other authors have no financial disclosures.
: This study has not received any funding from Allergan or any other company and the ethics committee approval was not required. Additionally, there were no human or animal subjects involved in this study.